- Home
- DMF vs CSBR Comparison
DMF vs CSBR Comparison
Compare DMF & CSBR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DMF
- CSBR
- Stock Information
- Founded
- DMF 1988
- CSBR 1985
- Country
- DMF United States
- CSBR United States
- Employees
- DMF N/A
- CSBR N/A
- Industry
- DMF Finance/Investors Services
- CSBR Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- DMF Finance
- CSBR Health Care
- Exchange
- DMF Nasdaq
- CSBR Nasdaq
- Market Cap
- DMF 152.2M
- CSBR 135.5M
- IPO Year
- DMF N/A
- CSBR 1986
- Fundamental
- Price
- DMF $7.23
- CSBR $8.85
- Analyst Decision
- DMF
- CSBR Strong Buy
- Analyst Count
- DMF 0
- CSBR 1
- Target Price
- DMF N/A
- CSBR $12.00
- AVG Volume (30 Days)
- DMF 60.7K
- CSBR 44.5K
- Earning Date
- DMF 01-01-0001
- CSBR 03-11-2025
- Dividend Yield
- DMF 2.66%
- CSBR N/A
- EPS Growth
- DMF N/A
- CSBR N/A
- EPS
- DMF 0.15
- CSBR 0.46
- Revenue
- DMF N/A
- CSBR $58,591,000.00
- Revenue This Year
- DMF N/A
- CSBR $15.11
- Revenue Next Year
- DMF N/A
- CSBR $7.80
- P/E Ratio
- DMF $45.13
- CSBR $18.78
- Revenue Growth
- DMF N/A
- CSBR 19.03
- 52 Week Low
- DMF $5.37
- CSBR $3.60
- 52 Week High
- DMF $6.79
- CSBR $11.99
- Technical
- Relative Strength Index (RSI)
- DMF 50.66
- CSBR 42.25
- Support Level
- DMF $7.13
- CSBR $9.21
- Resistance Level
- DMF $7.29
- CSBR $9.97
- Average True Range (ATR)
- DMF 0.07
- CSBR 0.65
- MACD
- DMF -0.01
- CSBR -0.10
- Stochastic Oscillator
- DMF 40.00
- CSBR 31.45
About DMF BNY Mellon Municipal Income Inc.
BNY Mellon Municipal Income, Inc. is a non-diversified closed-end management investment company. Its investment objective is to maximize current income exempt from federal income tax to the extent consistent with the preservation of capital. The fund invests in municipal obligations that are rated investment grade and have maturities of less than one year. The company targets to invest in the sector such as education, pre-refunded muni, utility, transportation, healthcare, special tax, state/territory general obligations, industry revenue, and pollution control.
About CSBR Champions Oncology Inc.
Champions Oncology Inc is a USA based company which is engaged in the development and sale of state of the art technology solutions and products to personalize the development and use of oncology drugs. The company operates through one segment namely Personalized Oncology Solutions (POS) and Translational Oncology Solutions (TOS). Its POS business assists physicians in developing personalized treatment options for their cancer patients through tumor-specific data obtained from drug panels and related personalized oncology services. The TOS business assists pharmaceutical and biotechnology companies with their drug development process and offers studies or license tumors for use in studies. The company's revenue is majorly derived from research services.